Table 3.
Proportional changes in lesion percentage (PL%) overtime relative to T0 across the treatment groups
| Evaluation times | Group | ||
|---|---|---|---|
| Control | PRF | PRF/ACS | |
| T0/T0 | 1cd | 1 bc | 1 ab |
| T7/T0 | 1.3 ± 0.03 b | 0.95 ± 0.02 cd* | 0.99 ± 0.016 a* |
| T14/T0 | 1.3 ± 0.02 b | 1.12 ± 0.04 b* | 0.92 ± 0.019 b*# |
| T30/T0 | 1.4 ± 0.02 a | 1.31 ± 0.04 a | 0.78 ± 0.02 c*# |
| T60/T0 | 1.1 ± 0.03 c | 1.02 ± 0.04 bc | 0.81 ± 0.019 c*# |
| T90/T0 | 1.0 ± 0.02 d | 0.87 ± 0.01 d* | 0 d*# |
| T150/T0 | 0.65 ± 0.02 e | 0 e* | 0 d* |
Times with different superscript letters ( a, b, c, d, e ) are significantly different at p < 0.05
* there is a significant difference compared to the control group in the same time at p < 0.05
# there is a significant difference compared to the PRF group in the same time at p < 0.05